Clinical trial Recruiting at 1 site Observational Ages 18 and up

Contactless optical monitoring of dialysis fistulas and grafts with the PatenSee system

Official title: A Prospective International Multicenter, Non-Interventional, Single Arm, Blinded Feasibility Study to Assess the Contactless Optical Monitoring of AV Access Using the PatenSee System in Dialysis Patients

Run by PatenSee Ltd. · NCT07194395 · Data updated 2026-11-12

This study will test a contactless camera-based system (PatenSee) to monitor arteriovenous fistulas or grafts in adults who receive regular hemodialysis.

More Hemodialysis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorPatenSee Ltd.
Industry-sponsored
Locations2 sites (Detroit, Michigan and 1 other locations)
StatusRecruiting
StartedJune 6, 2025
Main results expectedJune 2026
Study endsFebruary 28, 2027
Registry record updatedSeptember 26, 2025
Trial IDNCT07194395 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with non-reversible kidney failure who are on long-term hemodialysis through a functioning upper-extremity AV fistula or graft and who can give informed consent and follow study procedures are ideal candidates.

Probably not a fit

Patients with an active AV access infection, those expected to have imminent access revision or to recover kidney function/receive a transplant or change dialysis modality, or those unable to comply with study visits are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, non-interventional, single-arm international multicenter study enrolling up to 120 adults on maintenance hemodialysis with a functioning upper-extremity AV fistula or graft. Participants will receive standard clinical AV access exams by qualified staff and will also have the PatenSee system capture optical data weekly for 6 weeks and then every two weeks for up to 1 year. PatenSee data will be analyzed and compared against standard-of-care clinical monitoring and imaging, while all clinical decisions remain based on routine care. Additional information on imaging results and access-related complications will be collected to correlate with the device output.

Why it matters

Potential benefit: If successful, the PatenSee system could provide a non-contact way to detect access problems earlier and complement routine exams, potentially reducing delays to intervention and clinic visits.

How similar studies have gone: Small pilot studies and research on camera- or optical-based monitoring of vascular access have shown promising early results, but large multicenter evaluations of commercial contactless systems remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male and female adult patient aged ≥18 years old
2. Patient has a non-reversible kidney failure that requires long-term hemodialysis
3. Patient has a functioning AV access (AVF/G) in the upper extremity
4. Patient is able and willing to provide consent by signing an EC/IRB approved informed consent form
5. Patient is willing and able to follow the requirements of the study

Exclusion Criteria:

1. An active AV access infection
2. An AV access condition that will likely require revision, e.g., symptomatic steal syndrome
3. Expected to recover kidney function, receive a kidney transplant, transfer to peritoneal dialysis (PD) or transfer to non-study site during the study period.
4. Any reason per investigator's discretion for which the patient is not suitable for the study
5. Any medical or psychiatric illness, which in the opinion of the investigator would compromise the patient's ability to adhere to study requirements
6. Previous participation in an interventional study within 30 days prior to study enrollment that may interfere with evaluation of the study endpoints
7. Female patient is pregnant or breastfeeding

Where it's running

  • Henry Ford Hospital
    Detroit, Michigan, United States
    Recruiting
  • Meir Medical Center
    Kfar Saba, Hasharon, Israel
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.